Evidence map›Paper›PMID 36269889›Full record

ArticleACS sensors2022

Targeting Apollo-NADP

Huntley H Chang, Alex M Bennett, William D Cameron, Eric Floro, Aaron Au, Christopher M McFaul, Christopher M Yip, Jonathan V Rocheleau

Open access · greenAbstract read
In one paragraph

Article in ACS sensors, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Apollo-NADPScience advances · 2023
    Article
  7. Review
  8. Targeting Apollo-NADPACS sensors · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Huntley H ChangInstitute of Biomedical Engineering, University of Toronto, Toronto, Ontario M5S 3G9, Canada.ORCID 0000-0003-3181-8019
Alex M BennettInstitute of Biomedical Engineering, University of Toronto, Toronto, Ontario M5S 3G9, Canada.
William D CameronInstitute of Biomedical Engineering, University of Toronto, Toronto, Ontario M5S 3G9, Canada.
Eric FloroInstitute of Biomedical Engineering, University of Toronto, Toronto, Ontario M5S 3G9, Canada.
Aaron AuInstitute of Biomedical Engineering, University of Toronto, Toronto, Ontario M5S 3G9, Canada.
Christopher M McFaulInstitute of Biomedical Engineering, University of Toronto, Toronto, Ontario M5S 3G9, Canada.
Christopher M YipInstitute of Biomedical Engineering, University of Toronto, Toronto, Ontario M5S 3G9, Canada.ORCID 0000-0003-4507-556X
Jonathan V RocheleauInstitute of Biomedical Engineering, University of Toronto, Toronto, Ontario M5S 3G9, Canada.ORCID 0000-0002-1760-2564
University Health Network · CAUniversity of Toronto · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

NADPH/NADP

Indexed as

Insulin-Secreting CellsGlucoseMitochondriaNADPOxidation-ReductionGlucoseNADPfluorescence anisotropyfluorescent proteinFRETNADPH redoxorganelle targeting

Identifiers

PMID36269889
PMCPMC9706804
OpenAlexW4307028154

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.